# Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis

> **NCT01505088** · PHASE3 · COMPLETED · sponsor: **Eyegate Pharmaceuticals, Inc.** · enrollment: 193 (actual)

## Conditions studied

- Anterior Uveitis

## Interventions

- **DRUG:** 40 mg/mL Dexamethasone phosphate ophthalmic solution
- **DRUG:** Prednisolone Acetate (1%) Eyedrops
- **DRUG:** 100 mM sodium citrate buffer solution
- **DRUG:** Placebo Eyedrops

## Key facts

- **NCT ID:** NCT01505088
- **Lead sponsor:** Eyegate Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505088, "Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01505088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*